Matthew R. Thompson

发表

John Baba, Matthew R. Thompson, Robert G. Berger, 2011, Health Informatics J..

ATF3 transcription factor and its emerging roles in immunity and cancer

Matthew R. Thompson, Dakang Xu, Bryan R. G. Williams, 2009, Journal of Molecular Medicine.

ATF 3 repression of BCL-X L determines apoptotic sensitivity to HDAC inhibitors across tumour types

Erinna F. Lee, Matthew R. Thompson, J. Mariadason, 2017 .

Activating transcription factor 3 contributes to Toll-like receptor-mediated macrophage survival via repression of Bax and Bak.

Matthew R. Thompson, B. Williams, Dakang Xu, 2013, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

ATF3 Repression of BCL-XL Determines Apoptotic Sensitivity to HDAC Inhibitors across Tumor Types

Erinna F. Lee, Matthew R. Thompson, J. Mariadason, 2017, Clinical Cancer Research.

Correction: ATF3 Repression of BCL-XL Determines Apoptotic Sensitivity to HDAC Inhibitors Across Tumor Types.

Matthew R. Thompson, J. Mariadason, A. Dhillon, 2023, Clinical Cancer Research.